Mounjaro (tirzepatide): The newest diabetes and obesity medication (explanation and overview)

Update: Dr. Christopher McGowan, MD, has joined Bariendo, a national leader in endoscopic weight loss care (formerly of True You Weight Loss). Learn more at https://www.bariendo.com Tirzepatide (brand name: Mounjaro) is the newest injectable medication for the treatment of type II diabetes and obesity. Mounjaro was recently approved for diabetes and is awaiting FDA approval for the primary treatment of obesity. Based on the results of the SURMOUNT trial, tirzepatide will likely be the most effective obesity medication EVER. This once per week injection produced an average weight loss of nearly 21% of body weight at 72 weeks. In this video, Dr. Christopher McGowan, MD, MSCR, of True You Weight Loss, explains how tirzepatide (Mounjaro) works, common side effects, expectations, and a comparison to other weight loss medications. #obesitytreatment #obesity #weightloss #weightlosstreatment